Parental Experience of Potential Adverse Drug Reactions Related to Their Oral Administration of Antipyretic Analgesic Medicines in Children in Saudi Arabia

Mansour Tobaiqy; Katie MacLure; Mansoor Radwi; Ashwaq M Almalki; Ahmed H Alhasan; Maya Tannoury; Zouhair Attieh

doi:10.1016/j.curtheres.2020.100592

Parental Experience of Potential Adverse Drug Reactions Related to Their Oral Administration of Antipyretic Analgesic Medicines in Children in Saudi Arabia

Curr Ther Res Clin Exp. 2020 Jun 20:92:100592. doi: 10.1016/j.curtheres.2020.100592. eCollection 2020.

Authors

Mansour Tobaiqy¹, Katie MacLure², Mansoor Radwi³, Ashwaq M Almalki⁴, Ahmed H Alhasan¹, Maya Tannoury⁵, Zouhair Attieh⁵

Affiliations

¹ Department of Pharmacology, College of Medicine, University of Jeddah, Jeddah, P.O. Box 45311 Jeddah 21512, Makkah, Saudi Arabia.
² School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, Scotland, United Kingdom.
³ Department of Hematology, College of Medicine, University of Jeddah, Jeddah, Makkah, Saudi Arabia.
⁴ Department of Ophthalmology, King Abdulaziz Medical City, Jeddah, Makkah, Saudi Arabia.
⁵ Faculty of Health Sciences, American University of Science and Technology, Beirut, Lebanon.

Abstract

Background: Oral antipyretic analgesic medicines are commonly used in children and have the potential for adverse drug reactions (ADRs).

Objective: The aim of this study was to explore parental experiences of potential ADRs related to their oral administration of antipyretic analgesics in children in the Kingdom of Saudi Arabia.

Methods: For this cross-sectional survey, a paper-based questionnaire, consent form and information sheet were handed out to 1000 parents who had administered an oral antipyretic analgesic medicine to their children during the previous 3 months. Data were entered and analyzed using SPSS version 21.0 (IBM-SPSS Inc, Armonk, NY). Simple descriptive and inferential statistics were used. Management and ethical approvals were attained.

Results: During March to April 2017, 661 parents agreed to participate, giving a response rate of 66.1%. Of the surveyed sample, 208 parents had observed 1 or more potential ADRs (31.5%, n = 208 out of 661). Parents' (n = 208) most commonly reported potential ADRs (n = 523) were loss of appetite (23%, n = 120 out of 523), stomachache (20.3%, n = 106 out of 523), abdominal colic (13%, n = 68 out of 523), and diarrhea (10.3%, n = 54 out of 523). Parents described severity of the ADRs as slight (71.8%, n = 342 out of 476), annoying to the child (7.9%, n = 85 to of 476), significant and affecting daily tasks (3.6%, n = 17 out of 476) and significant and led to the hospital (6.7%, n = 32 out of 476). Fever was the top-ranked reason for using antipyretic analgesic medicines (41.0%, n = 271 out of 661), followed by toothache (25.0%, n = 165 out of 661) and tonsillitis/laryngitis (24.7%, n = 163 out of 661). Among parents, 34.7% (n = 165 out of 476) did not seek medical attention when a potential ADR occurred, whereas 26.3% (n = 125 out of 476) of parents took their children to hospital clinics.

Conclusions: Although the majority of parentally reported (but not proven) ADRs were mild, a number of significant ADRs were reported. Future research should consider whether there is a role for physicians and pharmacists in educating parents in Saudi Arabia, and perhaps more widely, about the optimal use of oral antipyretic and analgesic medicines in children. (Curr Ther Res Clin Exp. 2020; 81:XXX-XXX)© 2020 Elsevier HS Journals, Inc.

Keywords: adverse drug reactions; antipyretic analgesics; children; parents; survey.